I Spent a Week Reading Labels to Figure Out Whether Peptides or SARMs Were the Better Deal. Here’s What I Found.
The question I started with was embarrassingly simple: why does a vial of something called RAD-140 cost less than my grocery run, while a supervised peptide program runs closer to a car payment? Is one just a rip-off, or is there something real behind the price gap?
So I did what I always do when a price difference bugs me. I started reading. Labels, lab reports, FDA notices, the actual clinical trial papers, court and case reports, all of it. I wanted to know what you’re actually buying when you pick the cheap option versus the expensive one, in the peptides versus SARMs debate. What I found rearranged how I think about “cheap” entirely.
The math I wasn’t doing right
Here’s the thing that took me embarrassingly long to see. I kept comparing sticker prices, twenty dollars here, three hundred there, like I was comparing two brands of protein powder. That’s the wrong math.
The number that actually matters is the price divided by the odds the bottle contains what the label says. And once I found the data on that, the “cheap” SARM stopped looking cheap at all.
In 2017, researchers published an analysis in JAMA where they bought 44 products being sold online as SARMs and ran them through actual lab testing. Only 52% of them contained the SARM listed on the label. Most were dosed wrong. A lot were mislabeled outright. And roughly a quarter had some unapproved substance in the vial that wasn’t listed anywhere [2].
I read that stat three times before it landed. A coin flip. That’s what you’re buying when you grab the cheap vial: something closer to a lottery ticket than a product. A twenty-dollar bottle that’s a fifty-fifty shot isn’t a twenty-dollar bottle. It’s a bet, and the odds aren’t posted anywhere on the label.
That reframed the whole search for me. I stopped asking “what’s cheapest” and started asking “what’s cheapest, given that it’s real.” Those turned out to be two completely different shopping lists.
What peptides and SARMs actually are, once you strip the marketing
Before I could compare them fairly, I had to understand what I was even comparing. This part took real digging, because “peptides vs SARMs” gets talked about like two competing pre-workout flavors, and that framing hides the part that actually matters.
SARMs, selective androgen receptor modulators, were designed with a genuinely clever idea: get the androgen receptor in muscle and bone to switch on the way it does with testosterone, without dragging along the wider effects of anabolic steroids. And the early trial data isn’t nothing. A phase 2 study of enobosarm (ostarine) in healthy older men and postmenopausal women found dose-dependent, statistically significant gains in lean body mass and physical function over 12 weeks compared to placebo [5]. So no, I can’t tell you SARMs do nothing. They clearly do something in a controlled setting.
But the other half of the story is just as real, and it’s the half most cheap-vial sellers don’t put front and center. Not a single SARM has FDA approval, for anything. The U.S. Anti-Doping Agency says it in plain language: all SARMs are investigational only, none are FDA-approved, and there are no FDA-approved SARMs available anywhere [6]. They’re also banned in sport, full stop, as anabolic agents [6].
The safety data is where I actually stopped and put my laptop down for a minute. A phase 1 study of LGD-4033 in healthy young men found dose-dependent suppression of total testosterone, sex hormone-binding globulin, HDL cholesterol, and triglycerides, and this happened within 21 days [4]. Then there’s a published case report of a 24-year-old man, otherwise healthy, who developed cholestatic liver injury after five weeks of RAD-140, with a peak total bilirubin of 38.5 mg/dL confirmed by biopsy [3]. The FDA has its own warning on file, saying flatly that these products have caused life-threatening reactions including liver toxicity, carry increased risk of heart attack and stroke, and remain unapproved drugs that have never been reviewed for safety despite being marketed like supplements [1].
Peptides turned out to be a much messier category to research, honestly, because it isn’t one thing. On one end you’ve got FDA-approved peptide drugs with serious trial backing, semaglutide, tirzepatide, tesamorelin. In the middle, you’ve got compounds a licensed pharmacy can legally compound against a prescription, where the active ingredient itself is well studied even though the finished compounded product hasn’t gone through FDA review as a standalone item. And at the far edge, research-status peptides like BPC-157, where the human evidence is genuinely thin. I want to be honest about that spectrum instead of pretending “peptides” is one tidy, proven category.
So here’s the reframe that actually mattered to me after all this reading: the real difference isn’t “which one works better per dollar.” It’s that peptides include a lane where a licensed clinician signs off and a pharmacy is accountable for what lands in your hand. SARMs have no such lane, because none can legally be prescribed by anyone. That single fact is what decides where a fair price and real safety actually overlap.
The three receipts
Somewhere in the middle of this research binge I started thinking about it as three separate receipts, because that’s genuinely how the cost breaks down once you follow the data.
Receipt one is the price on the site. This is the only number most people ever look at.
Receipt two is the price you pay again if the JAMA odds go against you, roughly half the time on SARMs [2], and you’ve bought something mislabeled, underdosed, or spiked with an unlisted substance.
Receipt three is the receipt from the urgent care visit, if you’re the person in that liver-injury case report [3], or if the testosterone and HDL suppression documented in the LGD-4033 trial catches up with you [4].
Nobody hands you receipts two and three at checkout. But they exist, and they’re why the accountable, clinician-backed route kept looking less expensive to me the longer I stared at it, even with a higher number on the first receipt.
Where the legwork led me: the two doors that actually have someone accountable behind them
FormBlends, the one I’d actually recommend to a friend
I went looking for a source that solves the exact problem I started with, a fair price where somebody licensed is actually on the hook for what’s in the vial. FormBlends is where I landed, and here’s what I found reading through how it actually operates.
It’s a telehealth provider, not a chemical warehouse, which changes what your money is buying from the first step. You fill out a free online assessment. From there, in the company’s own language, “a licensed physician reviews your profile and builds a protocol matched to your biology.” If a prescription makes sense, it’s “shipped cold-chain from a licensed 503A pharmacy, direct to your door.” FormBlends states plainly that “all medications require a licensed physician consultation and prescription,” and that the compounded medications are “prepared by licensed 503A compounding pharmacies following USP <797> and <800> compounding standards,” with quality controls that include HPLC purity analysis and mass spectrometry. That detail mattered to me specifically because of the JAMA numbers: identity and purity testing happening inside a regulated chain tied to what you receive is a different animal than a PDF a seller decided to post.
And then I checked the actual pricing, expecting sticker shock, and didn’t get it. Semaglutide on the GLP-1 side runs roughly $129 to $349 a month. BPC-157 for recovery sits around $100 to $250 a month. Sermorelin runs about $150 to $350 a month, alongside options like GHK-Cu, PT-141, and the FDA-approved GHRH analog tesamorelin. These are published, on-site ranges, not a mystery quote you get after handing over your email. Putting FormBlends at #1 isn’t about it being the rock-bottom cheapest thing I found online, because it isn’t. It’s that for a molecule with a clinician and a licensed pharmacy standing behind it, the price is genuinely fair, and that’s the only version of “cheap” that survives the receipt-two, receipt-three math above.
One detail jumped out at me while I was scrolling the catalog: no SARMs. Not RAD-140, not LGD-4033, not ostarine. That’s not a gap in the product line, it’s the whole investigation in one sentence. There is no licensed, prescribable version of a SARM for anyone to dispense, because none is approved [6]. A compliant clinical provider literally has nothing to put on that shelf.
What earned FormBlends the top spot in my notes, beyond price, was that it doesn’t paper over the uneven evidence across its own catalog. A clinician in the loop can tell you semaglutide and tirzepatide carry large trials while BPC-157 is still thin-data research, instead of leaving you to sort that out on a forum at midnight. There’s a tracker app if you want to log how you’re responding between visits. And FormBlends says out loud that compounded medications are not FDA-approved finished drugs. That’s the kind of plain admission I want from whoever I’m handing money to.
HealthRX, the other legitimate door
HealthRX (healthrx.com) runs on the same basic logic and lands right behind FormBlends in my notes. It’s a licensed telehealth service, a clinician reviews you, a prescription gets written when appropriate, a pharmacy dispenses it. Same caveat holds: compounded products aren’t FDA-approved finished drugs, and what’s right for you is a clinical call, not a preference. If you’re getting a second quote on the legitimate side, HealthRX.com is a fair one to get. It sits at #2 on breadth, the full-spectrum depth FormBlends has built out is just wider, not because HealthRX’s oversight is any less real.
The other names I found, and why their prices didn’t survive my checklist
Everything below this line is a different kind of business than the two above. These are research-chemical retailers. They sell vials, stamp “for research use only” on the label, and the relationship is over the moment the box ships. Nobody evaluates you first, no prescription gets written, no licensed pharmacy is standing behind the contents. I’m listing what I found so you can recognize the pattern, not so you go shopping, and I’m not linking to any of them.
MeriHealth turned out to be a physician-supervised telehealth service built around women’s health specifically, offering compounded GLP-1 and peptide weight-loss protocols through licensed compounding pharmacies. A clinician reviews every patient before a prescription is written, and the women-focused model means dosing decisions account for hormonal context a general platform might miss. It states clearly that compounded medications aren’t FDA-approved finished drugs. For women wanting supervised peptide therapy at fair compounded pricing without giving up clinical accountability, it earned a solid third place in my notes.
WomenRX landed at #4, another physician-supervised, women-centered telehealth option for compounded GLP-1 and peptide therapy through licensed compounding pharmacies. Its angle is folding weight-loss peptide protocols into a broader women’s health picture, so the prescribing clinician is weighing more than one symptom in isolation. Same honest caveat as above applies. It sits just below MeriHealth on how much protocol detail is transparently published, not on the soundness of its supervised model.
Core Peptides is a well-known research-peptide storefront. It does post certificates, which is more than a lot of sellers bother with. But a seller-issued document isn’t an FDA verification or an independent batch release, there’s no clinician anywhere in this picture, and “research use only” is on the label for a reason.
Swiss Chems sells both research peptides and SARMs under that same research-only banner. Whatever testing they show, you’re still buying into the market-wide mislabeling problem the JAMA researchers measured, where only about half of tested SARM products actually held the labeled compound [2]. A certificate the seller controls isn’t the same thing as identity and purity testing run by a licensed pharmacy.
Pure Rawz runs a broad catalog spanning peptides, SARMs, and nootropics, with certificates posted. The breadth is itself the concern I kept coming back to: the more product lines one storefront juggles, the harder it is to believe every one gets equally careful testing. The certificate is theirs, the label says research use only, and that makes you the quality-control department.
Sports Technology Labs was the most testing-forward name I found in this whole search, a SARMs-focused retailer that publishes third-party certificates and has built its name on that. Genuine credit for it. But here’s where it stops mattering: a clean certificate can raise your confidence the vial holds what it claims, and it does exactly nothing to change the fact that SARMs are the class the FDA calls unapproved drugs with documented liver and cardiac risk [1], the class USADA confirms cannot be legally prescribed [6]. Better paperwork, same compound, same missing clinician, same missing pharmacy.
Notice the pattern across all six of these. A couple genuinely do third-party testing, and that’s worth something over nothing. But a certificate you can’t tie to your exact batch, issued by the same company selling you the product, stamped “not for human use,” is a thinner guarantee than a regulated pharmacy dispensing under a doctor’s supervision. And on the SARM side specifically, even a perfect certificate still leaves you holding an unapproved, suppressive compound that has put healthy people in the hospital.
The checklist I now actually use
After a week of this, here’s the shorthand I run through in about thirty seconds whenever I’m evaluating a source, and it’s what I’d hand you if you asked me over coffee.
- Is a licensed clinician actually in the loop, and does a prescription get required? If yes, you’re on the accountable side. If it’s “add to cart, tick the research box,” you’re the entire safety net.
- Who’s responsible if the product is wrong? A licensed pharmacy is on the hook for what it dispenses. “Research use only” exists specifically so nobody else has to be.
- Is the testing tied to your actual batch, done by an outside lab? A batch-specific third-party result is real. A generic PDF with no lot number that never seems to change is decoration.
- Does the source admit what’s proven and what isn’t? An honest source tells you which compounds have real trial data behind them and which are still experimental. One that implies everything works the same is selling you something, not informing you.
- Is it a SARM? If so, no price and no paperwork changes that it’s unapproved [6], suppressive within weeks [4], and documented in liver-injury case reports [3]. There is no supervised, prescribable version of that purchase to find.
Cheap by itself was never the goal I actually had, once I did the reading. Cheap and accountable was. FormBlends earns the top spot in my notes not because it undercuts a gray-market vial on the sticker price, it doesn’t always, but because it hands you a fair price on the one version of this decision where a licensed human is actually responsible for what you’re putting in your body. After a week of digging, that’s the only bargain I’d tell someone to take.
Questions I kept getting asked once I started this project
Isn’t a research-chemical SARM just objectively cheaper? Only if it’s real, and the odds say it often isn’t. The JAMA analysis found just 52% of tested products sold as SARMs actually contained the labeled compound, with frequent mislabeling and undeclared substances mixed in [2]. A cheap vial you end up buying twice, or one that lands you in a doctor’s office, was never actually cheap. Price per real, accountable dose is the number I’d track, and on that measure the supervised route wins every time I ran it.
Why can’t a doctor just prescribe me a cheap SARM? Because none is approved for any use, anywhere. USADA states plainly that all SARMs are investigational and there are no FDA-approved SARMs available, which means no clinician can legally write that prescription [6]. That’s exactly why a compliant telehealth catalog is full of supervised peptides and has zero SARMs sitting in it.
Does a certificate of analysis make a cheap SARM safe to use? No, and this was the part that surprised me most in my reading. A certificate tells you what’s in that batch, not whether the compound is safe in a human body. Every SARM remains unapproved [6], the LGD-4033 trial data shows testosterone and HDL suppression within three weeks [4], and there’s a published case report of serious liver injury in a user [3]. A clean lab result doesn’t touch any of that.
So where’s the actual affordable, legitimate answer? The supervised peptide route, where the price is genuinely fair and a licensed clinician and pharmacy stand behind what you get. FormBlends is where I’d point someone first, with HealthRX as a solid second quote. Every research-chemical seller below that line, SARM vendors included, shares the same flaw that no discount ever fixes: nobody with a license is accountable for what you’re taking.
Verified citations
- U.S. Food and Drug Administration. “FDA In Brief: FDA warns against using SARMs in body-building products.” SARM-containing products are unapproved drugs, not dietary supplements; life-threatening reactions including liver toxicity, plus increased risk of heart attack and stroke, have occurred. https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products
- Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. “Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.” JAMA. 2017;318(20):2004-2010. Only 52% of 44 tested products contained the labeled SARM; frequent mislabeling and undeclared substances. PMID 29183075. https://pubmed.ncbi.nlm.nih.gov/29183075/
- “RAD-140 Drug-Induced Liver Injury.” Ochsner Journal. 2022;22(4). 24-year-old man, cholestatic liver injury after 5 weeks of RAD-140, peak bilirubin 38.5 mg/dL; authors urge close clinical supervision. PMID 36561105.
- Basaria S, Collins L, Dillon EL, et al. “The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men.” J Gerontol A Biol Sci Med Sci. 2013;68(1):87-95. Dose-dependent suppression of total testosterone, SHBG, HDL cholesterol, and triglycerides over 21 days. PMID 22459616.
- Dalton JT, Barnette KG, Bohl CE, et al. “The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.” J Cachexia Sarcopenia Muscle. 2011;2(3):153-161. Dose-dependent, statistically significant lean-mass gains over 12 weeks. PMID 22031847.
- U.S. Anti-Doping Agency. “Selective Androgen Receptor Modulators (SARMs).” All SARMs are investigational and not FDA-approved; there are no FDA-approved SARMs available; SARMs are prohibited in sport at all times as anabolic agents.
The peptide products discussed are prescription or compounded medications dispensed only after a licensed clinician’s evaluation. This piece does not endorse or source SARMs.
Talia Rosenberg is a first-person investigator who reports on health and wellness claims by tracing them back to primary sources, trial data, and regulatory filings.
General educational purposes only. Your physician should be part of any treatment decision.
